HK1253046A1
(en )
2019-06-06
Heterocyclic compounds for the treatment of neurological and psychological disorders
GB0910003D0
(en )
2009-07-22
Novel compounds for the treatment of neurodegenerative diseases
IL253293A0
(en )
2017-09-28
Desferrioxamine-metal complexes for the treatment of immune-related disorders
IL217901A0
(en )
2012-03-29
Treatment of bdnf-related disorders using laquninimod
ZA201107449B
(en )
2012-06-27
Compounds for the treatment of metabolic disorders
ZA201107446B
(en )
2012-06-27
Compounds for the treatment of metabolic disorders
GB0904284D0
(en )
2009-04-22
Compounds for the treatment of metabolic disorders
EP2618826A4
(en )
2014-04-02
Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders
GB0809476D0
(en )
2008-07-02
Treatment of neurodegenerative disorders
PL2477656T3
(en )
2017-09-29
Treatment of neurological conditions
ZA200908724B
(en )
2010-08-25
Spiro compounds for treatment of inflammatory disorders
EP2328584A4
(en )
2012-01-18
Treatment of neurological disorders using huperzine
ZA201204391B
(en )
2014-11-26
Compounds for the treatment of neurologic disorders
EP2212246B1
(en )
2018-04-11
Treatment of neurological disorders
IL207906A0
(en )
2010-12-30
Treatment for ocular-related disorders
EP2387565A4
(en )
2012-07-11
2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
EP2240024A4
(en )
2014-05-21
Compounds for the treatment of metabolic disorders
HU0900722D0
(en )
2010-01-28
Compounds for the treatment of neurological disorders
GB0918626D0
(en )
2009-12-09
Therspeutics for neurological disorders
IL219050A0
(en )
2012-06-28
Pharmaceutical composition for the treatment of bladder disorders
GB0904286D0
(en )
2009-04-22
Compounds for the treatment of metabolic disorders
GB0904288D0
(en )
2009-04-22
Compounds for the treatment of metabolic disorders
GB0904289D0
(en )
2009-04-22
Compounds for the treatment of metabolic disorders
GB0904290D0
(en )
2009-04-22
Compounds for the treatment of metabolic disorders
IL218160A0
(en )
2012-07-31
Desferrioxamine-metal complexes for the treatment of immune-related disorders